Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2011; 17(8): 987-995
Published online Feb 28, 2011. doi: 10.3748/wjg.v17.i8.987
Published online Feb 28, 2011. doi: 10.3748/wjg.v17.i8.987
Figure 2 Intraperitoneal glucose tolerance test and insulin tolerance test in diabetic rats after 8 wk of treatment.
A: Serum glucose during intraperitoneal glucose tolerance test (IPGTT) in diabetic rats (n = 5/group); B: Percentage of initial glucose level during insulin tolerance test (ITT) in diabetic rats (n = 5/group). YQZMT: Yi-Qi-Zeng-Min-Tang; CON: Control group; MOD: Type 2 diabetes model group; LDY: Low-dose YQZMT group; MDY: Medium-dose YQZMT group; HDY: High-dose YQZMT group; ROS: Rosiglitazone group. aP < 0.05, bP < 0.01 vs CON group; cP < 0.05, dP < 0.01 vs MOD group.
- Citation: Zhang Z, Xue HL, Liu Y, Wang WJ. Yi-Qi-Zeng-Min-Tang, a Chinese medicine, ameliorates insulin resistance in type 2 diabetic rats. World J Gastroenterol 2011; 17(8): 987-995
- URL: https://www.wjgnet.com/1007-9327/full/v17/i8/987.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i8.987